Pancreatic Cancer Research

ResearcherUniversity of SalernoNo recent work listed

Alessandra Rosati

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6675-0857; OpenAlex author ID A5055822030. Sources: OpenAlex.

Their work

Papers
9 (first author 3, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
37
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 2 papers

Papers 9

  1. Multianalyte Serum Biomarker Panel for Early Detection of Pancreatic Adenocarcinoma. Co-author DOI 10.1200/cci.22.00160↗
  2. Pancreatic Cancer-Secreted Proteins: Targeting Their Functions in Tumor Microenvironment. Last author DOI 10.3390/cancers15194825↗
  3. A genetic programming-based approach for classifying pancreatic adenocarcinoma: the SICED experience Co-author DOI 10.1007/s00500-022-07383-3↗
  4. Comment on: ‘Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients’ First author DOI 10.1038/s41416-020-1013-5↗
  5. Development of an anti-BAG3 humanized antibody for treatment of pancreatic cancer. Co-author DOI 10.1002/1878-0261.12492↗
  6. Combined effect of anti-BAG3 and anti-PD-1 treatment on macrophage infiltrate, CD8+ T cell number and tumour growth in pancreatic cancer. First author DOI 10.1136/gutjnl-2017-314225↗
  7. BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages. Co-author DOI 10.1038/ncomms9695↗
  8. Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival. Co-author DOI 10.1016/j.ajpath.2012.07.016↗
  9. The expression of the pro-apoptotic gene Air is inducible in human pancreatic adenocarcinoma cells. First author DOI 10.1002/jcp.22736↗

Closest collaborators

The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Maria Caterina Turco · 8 shared papers, 2011–2023 · strength 0.71
  2. Margot De Marco · 7 shared papers, 2012–2023 · strength 0.68
  3. Liberato Marzullo · 6 shared papers, 2015–2023 · strength 0.66
  4. Gianni D’Angelo · 2 shared papers, 2022–2023 · strength 0.38
  5. Anna Lisa Cammarota · 2 shared papers, 2022–2023 · strength 0.38
  6. Anna Maria Basile · 4 shared papers, 2015–2023 · strength 0.35
  7. Vincenzo De Laurenzi · 5 shared papers, 2012–2023 · strength 0.34
  8. Francesco Palmieri · 1 shared paper, 2022 · strength 0.20
  9. Vittoria Iorio · 3 shared papers, 2015–2019 · strength 0.18
  10. Matthew A. Firpo · 2 shared papers, 2015–2023 · strength 0.17
  11. Verena Damiani · 2 shared papers, 2018–2019 · strength 0.14
  12. Josh M. Bleicher · 1 shared paper, 2023 · strength 0.14
  13. Kajsa E. Affolter · 1 shared paper, 2023 · strength 0.14
  14. Courtney L. Scaife · 1 shared paper, 2023 · strength 0.14
  15. Douglas G. Adler · 1 shared paper, 2023 · strength 0.14
  16. Sean J. Mulvihill · 1 shared paper, 2023 · strength 0.14
  17. Ignacio Garrido‐Laguna · 1 shared paper, 2023 · strength 0.14
  18. Katherine E. Poruk · 1 shared paper, 2023 · strength 0.14
  19. Maria Carmela Pascale · 3 shared papers, 2011–2018 · strength 0.13
  20. Claudio Arra · 2 shared papers, 2015–2019 · strength 0.11
  21. Morena d’Avenia · 2 shared papers, 2011–2015 · strength 0.06
  22. Fabio F. di Mola · 2 shared papers, 2012–2015 · strength 0.06
  23. Pierluigi Di Sebastiano · 2 shared papers, 2012–2015 · strength 0.06
  24. Jelena Todoric · 1 shared paper, 2015 · strength 0.03
  25. David Arthur Tuveson · 1 shared paper, 2015 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.